Not a healthcare professional? Visit our Public site

report_adverse_events REPORT ADVERSE EVENT Login Register notification bell

Placeholder

    Contact us REQUEST A REPRESENTATIVE

    Your browser is not supported.

    To view this content, please use one of the following browsers:

    • Microsoft Edge
    • Chrome
    • Safari

    Expert Opinion

     

    Explore our collection of expert videos and articles that address the current issues faced by healthcare professionals in the management of asthma.

      asthmatalks

      Asthma Talks Video - Dr de Zeeuw

      Topic 1: Sharing asthma management during COVID time and beyond.

       

       

      Asthma Talks Video - Dr de Zeeuw 

      Topic 2: Dr de Zeeuw Topic 2 - Discussing the differences between DPI and pMDI inhalers.

       

       

      Asthma Talks Video - Dr Stephanie Korn 

      Topic 1 - This video covers "inhaler technique & training"

       

       

      Asthma Talks Video - Dr Stephanie Korn 

      Topic 2 - Focus on the pharmacological management of asthma in adults.

       

       

      Asthma Talks Video - Prof Hans-Joachim Kabitz

      Topic 1 - Discusses Maintenance and Reliever Therapy (MART) vs Maintenance in asthma management.

       

       

      Asthma Talks Video - Prof Hans-Joachim Kabitz

      Topic 2 - Discusses appropriate Asthma therapy introduction and optimisation of inhaled therapy in severe asthma

       

       

      asthmareads
      How can primary care professionals reduce the burden of asthma exacerbations and improve asthma control in the real world?

      How can primary care professionals reduce the burden of asthma exacerbations and improve asthma control in the real world?

      Respiratory-lungs-image
      Read More
      The ongoing dilemma of phenotyping vs stepping up or down in asthma therapy

      The ongoing dilemma of phenotyping vs stepping up or down in asthma therapy

      Respiratory-lungs-image
      Read More
      Optimising referral criteria to specialty care in severe asthma

      Optimising referral criteria to specialty care in severe asthma

      Respiratory-lungs-image
      Read More
        asthmatalks

        Asthma Talks Video - Dr de Zeeuw

        Topic 1: Sharing asthma management during COVID time and beyond.

         

         

        Asthma Talks Video - Dr de Zeeuw 

        Topic 2: Dr de Zeeuw Topic 2 - Discussing the differences between DPI and pMDI inhalers.

         

         

        Asthma Talks Video - Dr Stephanie Korn 

        Topic 1 - This video covers "inhaler technique & training"

         

         

        Asthma Talks Video - Dr Stephanie Korn 

        Topic 2 - Focus on the pharmacological management of asthma in adults.

         

         

        Asthma Talks Video - Prof Hans-Joachim Kabitz

        Topic 1 - Discusses Maintenance and Reliever Therapy (MART) vs Maintenance in asthma management.

         

         

        Asthma Talks Video - Prof Hans-Joachim Kabitz

        Topic 2 - Discusses appropriate Asthma therapy introduction and optimisation of inhaled therapy in severe asthma

         

         

          asthmareads
          How can primary care professionals reduce the burden of asthma exacerbations and improve asthma control in the real world?

          How can primary care professionals reduce the burden of asthma exacerbations and improve asthma control in the real world?

          Respiratory-lungs-image
          Read More
          The ongoing dilemma of phenotyping vs stepping up or down in asthma therapy

          The ongoing dilemma of phenotyping vs stepping up or down in asthma therapy

          Respiratory-lungs-image
          Read More
          Optimising referral criteria to specialty care in severe asthma

          Optimising referral criteria to specialty care in severe asthma

          Respiratory-lungs-image
          Read More

          Reporting adverse events

          Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

          Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.